Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Johnson

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Cell Reports|August 30, 2018
Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon FasciculationErin L Slosarek, Amber L Schuh, Iryna Pustova, et al.
The Journal of Clinical Investigation|August 27, 2014
SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed β cellsMelkam A Kebede, Angie T Oler, Trillian Gregg, et al.
Vaccine|July 1, 2014
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturingRuben O Donis, , C Todd Davis, et al.
Journal of Medicinal Chemistry|June 12, 2014
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitorsJason D Burch, Kevin Lau, John J Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2020
Infectious KoRV-related retroviruses circulating in Australian batsJoshua A Hayward, Mary Tachedjian, Claudia Kohl, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)Giancarlo Trani, John J Barker, Steven M Bromidge, et al.
Cell|April 20, 2019
SIRT6 Is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived SpeciesXiao Tian, Denis Firsanov, Zhihui Zhang, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Plos Pathogens|October 17, 2013
New world bats harbor diverse influenza A virusesSuxiang Tong, Xueyong Zhu, Yan Li, et al.
Cell Death and Differentiation|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastasesSnahel Patel, Joshua D Webster, Eugene Varfolomeev, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Cell Reports|August 30, 2018
Pathogenic TFG Mutations Underlying Hereditary Spastic Paraplegia Impair Secretory Protein Trafficking and Axon FasciculationErin L Slosarek, Amber L Schuh, Iryna Pustova, et al.
The Journal of Clinical Investigation|August 27, 2014
SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed β cellsMelkam A Kebede, Angie T Oler, Trillian Gregg, et al.
Vaccine|July 1, 2014
Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturingRuben O Donis, , C Todd Davis, et al.
Journal of Medicinal Chemistry|June 12, 2014
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitorsJason D Burch, Kevin Lau, John J Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2020
Infectious KoRV-related retroviruses circulating in Australian batsJoshua A Hayward, Mary Tachedjian, Claudia Kohl, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)Giancarlo Trani, John J Barker, Steven M Bromidge, et al.
Cell|April 20, 2019
SIRT6 Is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived SpeciesXiao Tian, Denis Firsanov, Zhihui Zhang, et al.
Journal of Medicinal Chemistry|October 30, 2025
Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory DiseasesSnahel Patel, Huifen Chen, Eugene Varfolomeev, et al.
Plos Pathogens|October 17, 2013
New world bats harbor diverse influenza A virusesSuxiang Tong, Xueyong Zhu, Yan Li, et al.
Cell Death and Differentiation|May 19, 2019
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastasesSnahel Patel, Joshua D Webster, Eugene Varfolomeev, et al.
Pageof 14